Literature DB >> 22093830

Gold nanoparticle-assisted delivery of small, highly structured RNA into the nuclei of human cells.

Sang-Mi Ryou1, Jong-Myung Kim, Ji-Hyun Yeom, Seogang Hyun, Sudeok Kim, Min Su Han, Si Wouk Kim, Jeehyeon Bae, Sangmyung Rhee, Kangseok Lee.   

Abstract

Previous studies have shown that functionalized gold nanoparticles (AuNPs) can be used as a general platform for loading and delivering DNA oligonucleotides and short hairpin RNA to living systems. Here, we report the ability of functionalized AuNP to deliver RNA aptamers into the nuclei of human cells. An in vitro-synthesized RNA aptamer specific to the β-catenin protein was delivered into the HepG2 human cell line more efficiently via functionalized AuNP than liposome-based delivery, and resulted in nearly complete inhibition of β-catenin binding to the p50 subunit of NF-κB in the nucleus. This inhibition led to repression of NF-κB p50-dependent transcription of CRP. Also, the β-catenin aptamer in the nucleus led to down-regulation of β-catenin-mediated transcriptional activity through the TCF complex and resulted in decrease in the levels of cyclin D, and c-myc mRNA by ~47% and ~57%, respectively. In addition, we used functionalized AuNP to deliver another RNA aptamer targeted to the p50 subunit of NF-κB into the A549 human cell line, and this was sufficient to induce apoptosis of the cells. Our findings demonstrate that AuNP GDS can be used to deliver small, highly structured RNA aptamers into the nucleus of human cells where they modulate the activity of transactivators by interacting with target proteins.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22093830     DOI: 10.1016/j.bbrc.2011.11.020

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

Review 1.  Recent advances in understanding oligonucleotide aptamers and their applications as therapeutic agents.

Authors:  Khaled S Allemailem; Ahmad Almatroudi; Mohammed A Alsahli; Ghaiyda Talal Basfar; Faris Alrumaihi; Arshad Husain Rahmani; Amjad Ali Khan
Journal:  3 Biotech       Date:  2020-11-24       Impact factor: 2.406

2.  Inorganic nanovectors for nucleic acid delivery.

Authors:  Sandhya Pranatharthiharan; Mitesh D Patel; Anisha A D'Souza; Padma V Devarajan
Journal:  Drug Deliv Transl Res       Date:  2013-10       Impact factor: 4.617

3.  Inhibition of Xenograft tumor growth by gold nanoparticle-DNA oligonucleotide conjugates-assisted delivery of BAX mRNA.

Authors:  Ji-Hyun Yeom; Sang-Mi Ryou; Miae Won; Mira Park; Jeehyeon Bae; Kangseok Lee
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

4.  A Comparison Between Recombinant Listeria GAPDH Proteins and GAPDH Encoding mRNA Conjugated to Lipids as Cross-Reactive Vaccines for Listeria, Mycobacterium, and Streptococcus.

Authors:  Hector Teran-Navarro; David Salcines-Cuevas; Ricardo Calderon-Gonzalez; Raquel Tobes; Jorge Calvo-Montes; Inmaculada Concepción Pérez-Del Molino Bernal; Sonsoles Yañez-Diaz; Manuel Fresno; Carmen Alvarez-Dominguez
Journal:  Front Immunol       Date:  2021-04-19       Impact factor: 7.561

5.  Cytotoxicity Induction by the Oxidative Reactivity of Nanoparticles Revealed by a Combinatorial GNP Library with Diverse Redox Properties.

Authors:  Shenqing Wang; Xiliang Yan; Gaoxing Su; Bing Yan
Journal:  Molecules       Date:  2021-06-14       Impact factor: 4.411

Review 6.  Gold Nanoparticles for Vectorization of Nucleic Acids for Cancer Therapeutics.

Authors:  Daniela Ferreira; David Fontinha; Catarina Martins; David Pires; Alexandra R Fernandes; Pedro V Baptista
Journal:  Molecules       Date:  2020-07-31       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.